Scarica l'app Stockscreener
235.00
0.24%
-0.57
Dopo l'orario di chiusura:
235.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$235.57
Aprire:
$233.55
Volume 24 ore:
2.53M
Relative Volume:
0.72
Capitalizzazione di mercato:
$165.99B
Reddito:
$24.27B
Utile/perdita netta:
$3.50B
Rapporto P/E:
48.36
EPS:
4.8589
Flusso di cassa netto:
$5.02B
1 W Prestazione:
+2.66%
1M Prestazione:
+4.69%
6M Prestazione:
+17.10%
1 anno Prestazione:
-1.30%
Intervallo 1D:
$233.32
$237.70
Intervallo di 1 settimana:
$227.23
$240.44
Portata 52W:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Confronta DHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Global Dental Equipment Market is expected to generate a revenue of USD 17.68 Billion by 2032, Globally, at 12.35% CAGR: Verified Market Research® - GlobeNewswire Inc.
Is Danaher Corporation stock trading at a premium valuation2025 Retail Activity & Precise Swing Trade Alerts - ulpravda.ru
Danaher Corp. Stock: Silent Monster Move Or Overhyped Snoozefest? - AD HOC NEWS
Buy Danaher Stock. It’s Ready to Put Post-Covid Malaise Behind It. - Barron's
Robeco Institutional Asset Management B.V. Increases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Cerity Partners LLC Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings - TechStock²
$1000 Placed in Danaher a Decade Ago Would Be Valued at This Amount Now - Bitget
Where Danaher Stands With Analysts - Benzinga
DHR: TD Cowen Raises Price Target to $270, Maintains "Buy" Ratin - GuruFocus
What insider purchases suggest about Danaher Corporation stockInstitutional Buying Trends & Ride the Trends That Billionaires Follow - ulpravda.ru
Danaher Corporation $DHR Shares Sold by Sivik Global Healthcare LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Sells 68,082 Shares of Danaher Corporation $DHR - MarketBeat
Here's What to Expect From Danaher's Next Earnings Report - Barchart.com
Is Danaher (DHR) Pricing In Too Much Optimism After Recent Steady Share Performance - Yahoo Finance
Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat
Assessing Danaher (DHR) Valuation As The Business Refocuses On Life Sciences And Diagnostics - simplywall.st
Greenleaf Trust Has $15.47 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Danaher to Present at J.P. Morgan Healthcare Conference - Yahoo Finance
Guggenheim Raises Price Target on DHR to $275, Maintains Buy Rat - GuruFocus
Panic Selling: Is Danaher Corporation stock a defensive play in 2025July 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Danaher’s Push Into Higher‑Margin Life Sciences Might Change The Case For Investing In DHR - simplywall.st
Railway Pension Investments Ltd Boosts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR) Stock Analysis: Evaluating a Strong Buy with 12.51% Upside Potential - DirectorsTalk Interviews
Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat
Danaher Corporation $DHR Stake Boosted by Capital Advisors Inc. OK - MarketBeat
Best sustainable companies to own in 2026 - Morningstar Australia
Danaher Corp Is Quietly Eating Wall Street — Are You Sleeping On DHR? - AD HOC NEWS
Guggenheim Boosts Danaher (NYSE:DHR) Price Target to $275.00 - MarketBeat
JARISLOWSKY FRASER Ltd Lowers Stake in Danaher Corporation $DHR - MarketBeat
GAM Holding AG Acquires 9,081 Shares of Danaher Corporation $DHR - MarketBeat
Altfest L J & Co. Inc. Sells 5,124 Shares of Danaher Corporation $DHR - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Single-Use Bioprocessing Products Market Set to Reach USD 36 - openPR.com
Bank Pictet & Cie Europe AG Increases Holdings in Danaher Corporation $DHR - MarketBeat
Ascent Group LLC Acquires 5,422 Shares of Danaher Corporation $DHR - MarketBeat
Vanderbilt University Takes Position in Danaher Corporation $DHR - MarketBeat
Allspring Global Investments Holdings LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To ConsiderDecember 29th - MarketBeat
Fortive Corp.: The Quiet Infrastructure Platform Powering the Next Industrial Upgrade - AD HOC NEWS
Danaher stock in focus: defensive quality meets cautious optimism as Wall Street updates its targets - AD HOC NEWS
Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain? - TradingView — Track All Markets
Meridian Financial Partners LLC Takes $896,000 Position in Danaher Corporation $DHR - MarketBeat
Calamos Wealth Management LLC Has $16.98 Million Stake in Danaher Corporation $DHR - MarketBeat
Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Follow NowDecember 28th - MarketBeat
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On - AD HOC NEWS
Biotech Stocks To ConsiderDecember 27th - MarketBeat
Simplify Asset Management Inc. Sells 10,166 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):